Tobacco use among adults initiating treatment for HIV infection in rural Uganda
Identifieur interne : 001F91 ( Pmc/Corpus ); précédent : 001F90; suivant : 001F92Tobacco use among adults initiating treatment for HIV infection in rural Uganda
Auteurs : Gina R. Kruse ; David R. Bangsberg ; Judith A. Hahn ; Jessica E. Haberer ; Peter W. Hunt ; Conrad Muzoora ; John P. Bennett ; Jeffrey N. Martin ; Nancy A. RigottiSource :
- AIDS and behavior [ 1090-7165 ] ; 2014.
Abstract
We conducted a longitudinal study of tobacco use among adults initiating antiretroviral therapy (ART) in Mbarara, Uganda where 11% of men and 3% of women use tobacco according to the 2011 Demographic and Health Survey. In a prospective cohort, self-reported tobacco use was assessed before starting ART and reassessed every 3–4 months. Plasma cotinine, a nicotine metabolite, was measured in a subset of adults pre-ART to verify self-report. Among 496 subjects, 50 (10%) reported current tobacco use (20% of men, 6% of women). Most (53%) adults with elevated cotinine levels (>15 ng/mL) reported no tobacco use. By 6 months after ART initiation, 33% of tobacco users had quit (95% CI=20–46%). By 5 years, 64% quit (95% CI=47–77%). Self-reported tobacco use among rural Ugandans starting ART was twice as common as among the local background population and use may be underreported. ART initiation could be an opportunity for tobacco cessation interventions.
Url:
DOI: 10.1007/s10461-014-0737-8
PubMed: 24638166
PubMed Central: 4294428
Links to Exploration step
PMC:4294428Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Tobacco use among adults initiating treatment for HIV infection in rural Uganda</title><author><name sortKey="Kruse, Gina R" sort="Kruse, Gina R" uniqKey="Kruse G" first="Gina R." last="Kruse">Gina R. Kruse</name><affiliation><nlm:aff id="A1">Division of General Medicine, Department of Medicine, Massachusetts General Hospital, Boston, MA</nlm:aff></affiliation><affiliation><nlm:aff id="A2">Harvard Medical School, Boston, MA</nlm:aff></affiliation><affiliation><nlm:aff id="A3">Tobacco Research and Treatment Center, Department of Medicine, Massachusetts General Hospital, Boston, MA</nlm:aff></affiliation></author><author><name sortKey="Bangsberg, David R" sort="Bangsberg, David R" uniqKey="Bangsberg D" first="David R." last="Bangsberg">David R. Bangsberg</name><affiliation><nlm:aff id="A4">Center for Global Health, Massachusetts General Hospital, Boston, MA</nlm:aff></affiliation><affiliation><nlm:aff id="A5">Mbarara University of Science and Technology, Mbarara, Uganda</nlm:aff></affiliation><affiliation><nlm:aff id="A6">Ragon Institute of MGH, MIT and Harvard University, Boston, MA</nlm:aff></affiliation></author><author><name sortKey="Hahn, Judith A" sort="Hahn, Judith A" uniqKey="Hahn J" first="Judith A." last="Hahn">Judith A. Hahn</name><affiliation><nlm:aff id="A7">Department of Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, CA</nlm:aff></affiliation><affiliation><nlm:aff id="A8">Department of Epidemiology and Biostatistics, University of California, San Francisco, CA</nlm:aff></affiliation></author><author><name sortKey="Haberer, Jessica E" sort="Haberer, Jessica E" uniqKey="Haberer J" first="Jessica E." last="Haberer">Jessica E. Haberer</name><affiliation><nlm:aff id="A1">Division of General Medicine, Department of Medicine, Massachusetts General Hospital, Boston, MA</nlm:aff></affiliation><affiliation><nlm:aff id="A4">Center for Global Health, Massachusetts General Hospital, Boston, MA</nlm:aff></affiliation></author><author><name sortKey="Hunt, Peter W" sort="Hunt, Peter W" uniqKey="Hunt P" first="Peter W." last="Hunt">Peter W. Hunt</name><affiliation><nlm:aff id="A7">Department of Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, CA</nlm:aff></affiliation></author><author><name sortKey="Muzoora, Conrad" sort="Muzoora, Conrad" uniqKey="Muzoora C" first="Conrad" last="Muzoora">Conrad Muzoora</name><affiliation><nlm:aff id="A5">Mbarara University of Science and Technology, Mbarara, Uganda</nlm:aff></affiliation></author><author><name sortKey="Bennett, John P" sort="Bennett, John P" uniqKey="Bennett J" first="John P." last="Bennett">John P. Bennett</name><affiliation><nlm:aff id="A8">Department of Epidemiology and Biostatistics, University of California, San Francisco, CA</nlm:aff></affiliation></author><author><name sortKey="Martin, Jeffrey N" sort="Martin, Jeffrey N" uniqKey="Martin J" first="Jeffrey N." last="Martin">Jeffrey N. Martin</name><affiliation><nlm:aff id="A8">Department of Epidemiology and Biostatistics, University of California, San Francisco, CA</nlm:aff></affiliation></author><author><name sortKey="Rigotti, Nancy A" sort="Rigotti, Nancy A" uniqKey="Rigotti N" first="Nancy A." last="Rigotti">Nancy A. Rigotti</name><affiliation><nlm:aff id="A1">Division of General Medicine, Department of Medicine, Massachusetts General Hospital, Boston, MA</nlm:aff></affiliation><affiliation><nlm:aff id="A2">Harvard Medical School, Boston, MA</nlm:aff></affiliation><affiliation><nlm:aff id="A3">Tobacco Research and Treatment Center, Department of Medicine, Massachusetts General Hospital, Boston, MA</nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">24638166</idno><idno type="pmc">4294428</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4294428</idno><idno type="RBID">PMC:4294428</idno><idno type="doi">10.1007/s10461-014-0737-8</idno><date when="2014">2014</date><idno type="wicri:Area/Pmc/Corpus">001F91</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">001F91</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Tobacco use among adults initiating treatment for HIV infection in rural Uganda</title><author><name sortKey="Kruse, Gina R" sort="Kruse, Gina R" uniqKey="Kruse G" first="Gina R." last="Kruse">Gina R. Kruse</name><affiliation><nlm:aff id="A1">Division of General Medicine, Department of Medicine, Massachusetts General Hospital, Boston, MA</nlm:aff></affiliation><affiliation><nlm:aff id="A2">Harvard Medical School, Boston, MA</nlm:aff></affiliation><affiliation><nlm:aff id="A3">Tobacco Research and Treatment Center, Department of Medicine, Massachusetts General Hospital, Boston, MA</nlm:aff></affiliation></author><author><name sortKey="Bangsberg, David R" sort="Bangsberg, David R" uniqKey="Bangsberg D" first="David R." last="Bangsberg">David R. Bangsberg</name><affiliation><nlm:aff id="A4">Center for Global Health, Massachusetts General Hospital, Boston, MA</nlm:aff></affiliation><affiliation><nlm:aff id="A5">Mbarara University of Science and Technology, Mbarara, Uganda</nlm:aff></affiliation><affiliation><nlm:aff id="A6">Ragon Institute of MGH, MIT and Harvard University, Boston, MA</nlm:aff></affiliation></author><author><name sortKey="Hahn, Judith A" sort="Hahn, Judith A" uniqKey="Hahn J" first="Judith A." last="Hahn">Judith A. Hahn</name><affiliation><nlm:aff id="A7">Department of Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, CA</nlm:aff></affiliation><affiliation><nlm:aff id="A8">Department of Epidemiology and Biostatistics, University of California, San Francisco, CA</nlm:aff></affiliation></author><author><name sortKey="Haberer, Jessica E" sort="Haberer, Jessica E" uniqKey="Haberer J" first="Jessica E." last="Haberer">Jessica E. Haberer</name><affiliation><nlm:aff id="A1">Division of General Medicine, Department of Medicine, Massachusetts General Hospital, Boston, MA</nlm:aff></affiliation><affiliation><nlm:aff id="A4">Center for Global Health, Massachusetts General Hospital, Boston, MA</nlm:aff></affiliation></author><author><name sortKey="Hunt, Peter W" sort="Hunt, Peter W" uniqKey="Hunt P" first="Peter W." last="Hunt">Peter W. Hunt</name><affiliation><nlm:aff id="A7">Department of Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, CA</nlm:aff></affiliation></author><author><name sortKey="Muzoora, Conrad" sort="Muzoora, Conrad" uniqKey="Muzoora C" first="Conrad" last="Muzoora">Conrad Muzoora</name><affiliation><nlm:aff id="A5">Mbarara University of Science and Technology, Mbarara, Uganda</nlm:aff></affiliation></author><author><name sortKey="Bennett, John P" sort="Bennett, John P" uniqKey="Bennett J" first="John P." last="Bennett">John P. Bennett</name><affiliation><nlm:aff id="A8">Department of Epidemiology and Biostatistics, University of California, San Francisco, CA</nlm:aff></affiliation></author><author><name sortKey="Martin, Jeffrey N" sort="Martin, Jeffrey N" uniqKey="Martin J" first="Jeffrey N." last="Martin">Jeffrey N. Martin</name><affiliation><nlm:aff id="A8">Department of Epidemiology and Biostatistics, University of California, San Francisco, CA</nlm:aff></affiliation></author><author><name sortKey="Rigotti, Nancy A" sort="Rigotti, Nancy A" uniqKey="Rigotti N" first="Nancy A." last="Rigotti">Nancy A. Rigotti</name><affiliation><nlm:aff id="A1">Division of General Medicine, Department of Medicine, Massachusetts General Hospital, Boston, MA</nlm:aff></affiliation><affiliation><nlm:aff id="A2">Harvard Medical School, Boston, MA</nlm:aff></affiliation><affiliation><nlm:aff id="A3">Tobacco Research and Treatment Center, Department of Medicine, Massachusetts General Hospital, Boston, MA</nlm:aff></affiliation></author></analytic><series><title level="j">AIDS and behavior</title><idno type="ISSN">1090-7165</idno><idno type="eISSN">1573-3254</idno><imprint><date when="2014">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p id="P1">We conducted a longitudinal study of tobacco use among adults initiating antiretroviral therapy (ART) in Mbarara, Uganda where 11% of men and 3% of women use tobacco according to the 2011 Demographic and Health Survey. In a prospective cohort, self-reported tobacco use was assessed before starting ART and reassessed every 3–4 months. Plasma cotinine, a nicotine metabolite, was measured in a subset of adults pre-ART to verify self-report. Among 496 subjects, 50 (10%) reported current tobacco use (20% of men, 6% of women). Most (53%) adults with elevated cotinine levels (>15 ng/mL) reported no tobacco use. By 6 months after ART initiation, 33% of tobacco users had quit (95% CI=20–46%). By 5 years, 64% quit (95% CI=47–77%). Self-reported tobacco use among rural Ugandans starting ART was twice as common as among the local background population and use may be underreported. ART initiation could be an opportunity for tobacco cessation interventions.</p></div></front></TEI><pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<pmc-dir>properties manuscript</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-journal-id">9712133</journal-id><journal-id journal-id-type="pubmed-jr-id">21042</journal-id><journal-id journal-id-type="nlm-ta">AIDS Behav</journal-id><journal-id journal-id-type="iso-abbrev">AIDS Behav</journal-id><journal-title-group><journal-title>AIDS and behavior</journal-title></journal-title-group><issn pub-type="ppub">1090-7165</issn><issn pub-type="epub">1573-3254</issn></journal-meta><article-meta><article-id pub-id-type="pmid">24638166</article-id><article-id pub-id-type="pmc">4294428</article-id><article-id pub-id-type="doi">10.1007/s10461-014-0737-8</article-id><article-id pub-id-type="manuscript">NIHMS594124</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Tobacco use among adults initiating treatment for HIV infection in rural Uganda</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>KRUSE</surname><given-names>Gina R.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref><xref ref-type="aff" rid="A3">3</xref><xref rid="FN1" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author"><name><surname>BANGSBERG</surname><given-names>David R.</given-names></name><xref ref-type="aff" rid="A4">4</xref><xref ref-type="aff" rid="A5">5</xref><xref ref-type="aff" rid="A6">6</xref></contrib><contrib contrib-type="author"><name><surname>HAHN</surname><given-names>Judith A.</given-names></name><xref ref-type="aff" rid="A7">7</xref><xref ref-type="aff" rid="A8">8</xref></contrib><contrib contrib-type="author"><name><surname>HABERER</surname><given-names>Jessica E.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>HUNT</surname><given-names>Peter W.</given-names></name><xref ref-type="aff" rid="A7">7</xref></contrib><contrib contrib-type="author"><name><surname>MUZOORA</surname><given-names>Conrad</given-names></name><xref ref-type="aff" rid="A5">5</xref></contrib><contrib contrib-type="author"><name><surname>BENNETT</surname><given-names>John P.</given-names></name><xref ref-type="aff" rid="A8">8</xref></contrib><contrib contrib-type="author"><name><surname>MARTIN</surname><given-names>Jeffrey N.</given-names></name><xref ref-type="aff" rid="A8">8</xref></contrib><contrib contrib-type="author"><name><surname>RIGOTTI</surname><given-names>Nancy A.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref><xref ref-type="aff" rid="A3">3</xref></contrib></contrib-group><aff id="A1"><label>1</label>Division of General Medicine, Department of Medicine, Massachusetts General Hospital, Boston, MA</aff><aff id="A2"><label>2</label>Harvard Medical School, Boston, MA</aff><aff id="A3"><label>3</label>Tobacco Research and Treatment Center, Department of Medicine, Massachusetts General Hospital, Boston, MA</aff><aff id="A4"><label>4</label>Center for Global Health, Massachusetts General Hospital, Boston, MA</aff><aff id="A5"><label>5</label>Mbarara University of Science and Technology, Mbarara, Uganda</aff><aff id="A6"><label>6</label>Ragon Institute of MGH, MIT and Harvard University, Boston, MA</aff><aff id="A7"><label>7</label>Department of Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, CA</aff><aff id="A8"><label>8</label>Department of Epidemiology and Biostatistics, University of California, San Francisco, CA</aff><author-notes><corresp id="FN1"><label>*</label>Corresponding author: 50 Staniford Street, 9<sup>th</sup> Floor, Boston, MA 02114, Telephone: 617-724-3157, Fax: 617-724-3544, <email>gkruse@mgh.harvard.edu</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>9</day><month>1</month><year>2015</year></pub-date><pub-date pub-type="ppub"><month>7</month><year>2014</year></pub-date><pub-date pub-type="pmc-release"><day>14</day><month>1</month><year>2015</year></pub-date><volume>18</volume><issue>7</issue><fpage>1381</fpage><lpage>1389</lpage><pmc-comment>elocation-id from pubmed: 10.1007/s10461-014-0737-8</pmc-comment>
<abstract><p id="P1">We conducted a longitudinal study of tobacco use among adults initiating antiretroviral therapy (ART) in Mbarara, Uganda where 11% of men and 3% of women use tobacco according to the 2011 Demographic and Health Survey. In a prospective cohort, self-reported tobacco use was assessed before starting ART and reassessed every 3–4 months. Plasma cotinine, a nicotine metabolite, was measured in a subset of adults pre-ART to verify self-report. Among 496 subjects, 50 (10%) reported current tobacco use (20% of men, 6% of women). Most (53%) adults with elevated cotinine levels (>15 ng/mL) reported no tobacco use. By 6 months after ART initiation, 33% of tobacco users had quit (95% CI=20–46%). By 5 years, 64% quit (95% CI=47–77%). Self-reported tobacco use among rural Ugandans starting ART was twice as common as among the local background population and use may be underreported. ART initiation could be an opportunity for tobacco cessation interventions.</p></abstract><kwd-group><kwd>Tobacco use</kwd><kwd>smoking cessation</kwd><kwd>socioeconomic status</kwd><kwd>resource-limited setting</kwd><kwd>antiretroviral treatment initiation</kwd></kwd-group></article-meta></front></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001F91 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 001F91 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaSubSaharaV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé= PMC:4294428
|texte= Tobacco use among adults initiating treatment for HIV infection in rural Uganda
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i -Sk "pubmed:24638166" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a SidaSubSaharaV1
| This area was generated with Dilib version V0.6.32. |  |